Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Ichimura

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
Brain Tumor Pathology|March 9, 2012
Molecular pathogenesis of IDH mutations in gliomasKoichi Ichimura
Neuro-Oncology|March 11, 2019
TERT promoter mutation as a diagnostic marker for diffuse gliomasKoichi Ichimura
No Shinkei Geka. Neurological Surgery|April 13, 2023
[World Health Organization Classification of Central Nervous System Tumours, 5<sup>th</sup> Edition:Points of the Update and the Current Status]Koichi Ichimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[TERT]Koichi Ichimura
Frontiers in Oncology|September 22, 2022
Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directionsHirokazu Takami, Koichi Ichimura
Seminars in Cancer Biology|January 28, 2019
Signal transduction pathways and resistance to targeted therapies in gliomaArata Tomiyama, Koichi Ichimura
Brain Tumor Pathology|January 31, 2022
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomasHideyuki Arita, Koichi Ichimura
Neuro-Oncology|July 9, 2021
MGMT testing always worth an emotionMonika E Hegi, Koichi Ichimura
No Shinkei Geka. Neurological Surgery|February 16, 2022
[Pediatric Hemispheric Glioma]Yoshiko Nakano, Koichi Ichimura, Hiroaki Sakamoto
Neuro-Oncology|October 26, 2012
Molecular markers in pediatric neuro-oncologyKoichi Ichimura, Ryo Nishikawa, Masao Matsutani
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
Brain Tumor Pathology|March 9, 2012
Molecular pathogenesis of IDH mutations in gliomasKoichi Ichimura
Neuro-Oncology|March 11, 2019
TERT promoter mutation as a diagnostic marker for diffuse gliomasKoichi Ichimura
No Shinkei Geka. Neurological Surgery|April 13, 2023
[World Health Organization Classification of Central Nervous System Tumours, 5<sup>th</sup> Edition:Points of the Update and the Current Status]Koichi Ichimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[TERT]Koichi Ichimura
Frontiers in Oncology|September 22, 2022
Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directionsHirokazu Takami, Koichi Ichimura
Seminars in Cancer Biology|January 28, 2019
Signal transduction pathways and resistance to targeted therapies in gliomaArata Tomiyama, Koichi Ichimura
Brain Tumor Pathology|January 31, 2022
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomasHideyuki Arita, Koichi Ichimura
Neuro-Oncology|July 9, 2021
MGMT testing always worth an emotionMonika E Hegi, Koichi Ichimura
No Shinkei Geka. Neurological Surgery|February 16, 2022
[Pediatric Hemispheric Glioma]Yoshiko Nakano, Koichi Ichimura, Hiroaki Sakamoto
Neuro-Oncology|October 26, 2012
Molecular markers in pediatric neuro-oncologyKoichi Ichimura, Ryo Nishikawa, Masao Matsutani
Pageof 30